Skip to main content

Table 5 Clinical events

From: Effect of alirocumab on coronary plaque in patients with coronary artery disease assessed by optical coherence tomography

 

Standard of care

(N = 31)

Alirocumab

(N = 30)

Adverse cardiac events

0

0

Cardiac death

0

0

Myocardial infarction

1

0

Ischemia driven target lesion revascularization,

  

Treatment-related adverse events

1

2

Nasopharyngitis

1

2

Injection-site reaction

0

1

Back pain

1

1

Transaminase elevation

 Â